Track: Cancer and Immunology

Cancer and Immunology

The session on "Cancer and Immunology" aims to explore the intricate relationship between the immune system and cancer development, as well as the role of immunology in advancing cancer treatments. This session will explore various aspects of cancer immunology, focusing on how the immune system can be harnessed to fight cancer and the complexities that arise in the interplay between immune responses and tumor developmentThe extensive range of systemic immune changes that take place during the development of cancer and the vital role of peripheral immune cells in the anticancer immune response have recently been made clear by recent studies.

Onco-Immunology discussion will also cover how onco-immunology has paved the way for treatments like immune checkpoint inhibitors, which have revolutionized cancer care, thereby enhancing the immune system's ability to combat cancer.

Carcinogenesis segment will explore how immune surveillance can both prevent and inadvertently contribute to tumor formation

Cancer Vaccines Discussions will include the success of vaccines like the HPV vaccine in preventing cervical cancer and ongoing research into personalized vaccines designed to target specific tumor antigens.

Immunotherapy sub-session will also highlight the potential of combining immunotherapy with traditional treatments to enhance overall treatment efficacy.

Chemotherapeutic Agents and Tumor Microenvironment sub-session will examine how it composed of immune cells, blood vessels, and signaling molecules, affects treatment outcomes. The role of chemotherapeutic agents in modulating the immune response and how they are being integrated will also be discussed.

Autoimmunity in Cancer Therapy segment will explore how clinicians manage these risks, balance treatment efficacy with patient safety, and the ongoing research aimed at minimizing autoimmune complications in cancer immunotherapy.